SUBHASH KUMAR WANGNOO

Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (<scp>EDGE</scp>)

Chantal Mathieu, Anthony Barnett, Helmut Brath et al. · International Journal of Clinical Practice · 2013 · 55 citations · Full text

Worldwide spread of COVID-19 Pandemic and risk factors among Co-morbid conditions especially Diabetes Mellitus in India

Sonia Mor, Prem Saini, SUBHASH KUMAR WANGNOO et al. · Research Journal of Pharmacy and Technology · 2020 · 40 citations · Full text

World Health Organization, Covid-19 Epidemiology, Non-communicable Disease +22

Cathepsin-D, Adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: A multicentric study

Jamal Ahmad, Mohammad Zubair, Abida Malik et al. · The Foot · 2012 · 34 citations

Diabetic Foot, Metabolic Syndrome, Diabetes Epidemiology +9

Cardiovascular risk in newly diagnosed type 2 diabetes patients in India

AG Unnikrishnan, Rakesh Sahay, Uday Phadke et al. · PLoS ONE · 2022 · 33 citations · Full text

Prevalence of glucose intolerance at 6 weeks postpartum in Indian women with gestational diabetes mellitus

Radhika Jindal, Mohammad A. Siddiqui, Nitin Gupta et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2015 · 24 citations

Indian Women, Diabetes, Gynecology +8